Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies. Mediterr J Hematol Infect Dis [Internet]. 2025 Aug. 31 [cited 2026 Apr. 30];17(1):e2025061. Available from: https://www.mjhid.org/mjhid/article/view/6063